Dominant negative effects of tumor necrosis factor (tnf)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by Formation of heteromeric complexes

Journal of Biological Chemistry

Volumn 289, Issue 23, 2014, Pages 16576-16587

  Neumann, Simon ^a,d   Hasenauer, Jan ^b,c   Pollak, Nadine ^a   Scheurich, Peter ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL MEMBRANES; CHEMICAL ACTIVATION; CROSSLINKING; LIGANDS; OLIGOMERS; PHOTOBLEACHING;

APOPTOSIS INDUCTION; CHEMICAL CROSS-LINKING; DOMINANT NEGATIVE; HETEROMERIC COMPLEXES; MEMBRANE RECEPTORS; MOLECULAR MECHANISM; SIGNALING SYSTEMS; TUMOR NECROSIS FACTORS;

SIGNALING;

DEATH RECEPTOR 4; DEATH RECEPTOR 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIMERIZATION; EMBRYO; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET); RECEPTOR; SIGNALING; TRAIL;

APOPTOSIS; DIMERIZATION; HELA CELLS; HUMANS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION;

EID: 84902186328     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.559468     Document Type: Article

References (36)

1. Johnstone, R. W., Frew, A. J., and Smyth, M. J. (2008) The TRAIL apoptotic pathway in cancer onset, progression, and therapy. Nat. Rev. Cancer 8, 782-798
2. Kimberley, F. C., and Screaton, G. R. (2004) Following a TRAIL: update on a ligand and its five receptors. Cell Res. 14, 359-372
3. Zinonos, I., Labrinidis, A., Lee, M., Liapis, V., Hay, S., Ponomarev, V., Diamond, P., Findlay, D. M., Zannettino, A. C., and Evdokiou, A. (2011) Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. J. Bone Miner. Res. 26, 630-643
4. De Toni, E. N., Thieme, S. E., Herbst, A., Behrens, A., Stieber, P., Jung, A., Blum, H., Göke, B., and Kolligs, F. T. (2008) OPG is regulated byβ-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. Clin. Cancer Res. 14, 4713-4718
5. Varfolomeev, E., Maecker, H., Sharp, D., Lawrence, D., Renz, M., Vucic, D., and Ashkenazi, A. (2005) Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 280, 40599-40608
6. Jin, Z., and El-Deiry, W. S. (2006) Distinct signaling pathways in TRAILversus tumor necrosis factor-induced apoptosis. Mol. Cell. Biol. 26, 8136-8148
7. Lee, H. W., Lee, S. H., Lee, H. W., Ryu, Y. W., Kwon, M. H., and Kim, Y. S. (2005) Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors. Biochem. Biophys. Res. Commun. 330, 1205-1212
8. Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., and Goodwin, R. G. (1997) The novel receptor TRAIL-R4 induces NF-βB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813-820
9. Truneh, A., Sharma, S., Silverman, C., Khandekar, S., Reddy, M. P., Deen, K. C., McLaughlin, M. M., Srinivasula, S. M., Livi, G. P., Marshall, L. A., Alnemri, E. S., Williams, W. V., and Doyle, M. L. (2000) Temperaturesensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J. Biol. Chem. 275, 23319-23325
10. Pan, G., Ni, J., Wei, Y.-F., Yu, G.-l., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818
11. Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C. P., DuBose, R. F., Goodwin, R. G., and Smith, C. A. (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186, 1165-1170
12. Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., and de Vos, A. M. (1999) Triggering cell death: the crystal structure of apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4, 563-571
13. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., and Lenardo, M. J. (2000) Adomain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354
14. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357
15. Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., and Chan, F. K. (2005) Preligand assembly domainmediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102, 18099-18104
16. Mongkolsapaya, J., Grimes, J. M., Chen, N., Xu, X.-N., Stuart, D. I., Jones, E. Y., and Screaton, G. R. (1999) Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 6, 1048-1053
17. Mérino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., and Micheau, O. (2006) Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol. Cell. Biol. 26, 7046-7055
18. Lalaoui, N., Morlé, A., Mérino, D., Jacquemin, G., Iessi, E., Morizot, A., Shirley, S., Robert, B., Solary, E., Garrido, C., and Micheau, O. (2011) TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT. PLoS ONE 6, e19679
19. Harper, N., Farrow, S. N., Kaptein, A., Cohen, G. M., and MacFarlane, M. (2001) Modulation of tumor necrosis factor apoptosis-inducing ligandinduced NF-βB activation by inhibition of apical caspases. J. Biol. Chem. 276, 34743-34752
20. Branschädel, M., Aird, A., Zappe, A., Tietz, C., Krippner-Heidenreich, A., and Scheurich, P. (2010) Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness. Cell. Signal. 22, 404-414
21. Boschert, V., Krippner-Heidenreich, A., Branschädel, M., Tepperink, J., Aird, A., and Scheurich, P. (2010) Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2. Cell. Signal. 22, 1088-1096
22. Winkel, C., Neumann, S., Surulescu, C., and Scheurich, P. (2012) A minimal mathematical model for the initial molecular interactions of death receptor signaling. Math. Biosci. Eng. 9, 663-683
23. Gerken, M., Krippner-Heidenreich, A., Steinert, S., Willi, S., Neugart, F., Zappe, A., Wrachtrup, J., Tietz, C., and Scheurich, P. (2010) Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors. Biochim. Biophys. Acta 1798, 1081-1089
24. Huang, D. C., Cory, S., and Strasser, A. (1997) Bcl-2, Bcl-x (L) and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14, 405-414
25. Krippner-Heidenreich, A., Tübing, F., Bryde, S., Willi, S., Zimmermann, G., and Scheurich, P. (2002) Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. J. Biol. Chem. 277, 44155-44163
26. Stepensky, D. (2007) FRETcalc plugin for calculation of FRET in noncontinuous intracellular compartments. Biochem. Biophys. Res. Commun. 359, 752-758
27. Papoff, G., Hausler, P., Eramo, A., Pagano, M. G., Di Leve, G., Signore, A., and Ruberti, G. (1999) Identification and characterization of a ligandindependent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem. 274, 38241-38250
28. Valley, C. C., Lewis, A. K., Mudaliar, D. J., Perlmutter, J. D., Braun, A. R., Karim, C. B., Thomas, D. D., Brody, J. R., and Sachs, J. N. (2012) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized. J. Biol. Chem. 287, 21265-21278
29. Lewis, A. K., Valley, C. C., and Sachs, J. N. (2012) TNFR1 signaling is associated with backbone conformational changes of receptor dimers consistent with overactivation in the R92Q TRAPS mutant. Biochemistry 51, 6545-6555
30. Gonzalvez, F., and Ashkenazi, A. (2010) New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29, 4752-4765
31. Azijli, K., Weyhenmeyer, B., Peters, G. J., de Jong, S., and Kruyt, F. A. (2013) Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell. Death. Differ. 20, 858-868
32. Richter, C., Messerschmidt, S., Holeiter, G., Tepperink, J., Osswald, S., Zappe, A., Branschädel, M., Boschert, V., Mann, D. A., Scheurich, P., and Krippner-Heidenreich, A. (2012) The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand. Mol. Cell. Biol. 32, 2515-2529
33. Tur, V., van der Sloot, A. M., Reis, C. R., Szegezdi, E., Cool, R. H., Samali, A., Serrano, L., and Quax, W. J. (2008) DR4-selective tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) variants obtained by structurebased design. J. Biol. Chem. 283, 20560-20568
34. Hu, W.-H., Johnson, H., and Shu, H.-B. (1999) Tumor necrosis factorrelated apoptosis-inducing ligand receptors signal NF-βB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274, 30603-30610
35. Meng, R. D., McDonald, E. R., 3rd., Sheikh, M. S., Fornace, A. J., Jr., and El-Deiry, W. S. (2000) The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. Mol. Ther. 1, 130-144
36. Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997) A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003-1006